- Acquired by Ferring Pharmaceuticals, Jan 2005
- Raised $15M funding round, May 2018
- Raised $4.1M funding round, Feb 2016
About
Bio-Technology General Israel (BTG) is an integrated biopharmaceutical services company that develops and manufactures healthcare products derived from genetic engineering and biotechnology processes. BTGs Biolon, first introduced in 1993, is an injectable system containing 1% fermentation-derived sodium hyaluronate (NaHA) used as a viscoelastic aid in cataract and other ophthalmic surgeries. Euflexxa is a treatment to help relieve knee pain due to osteoarthritis (OA). It is used by thousands of people to help manage OA knee pain and stay active. Containing 1% fermentation-derived sodium hyaluronate, Euflexxa is intended for intra-articular injection into the knee. Developed in the 1980s, BTGs recombinant human growth hormone (somatropin for injection or hGH) first gained regulatory approval in 1988. It is identical to natural human growth hormone synthesized by the pituitary gland, and is used to treat Turner syndrome and growth hormone deficiency in children. BTG is a wholly owned subsidiary of Ferring Pharmaceuticals.
Funding history · 4 rounds · $26.9M total
Q&A
- What is BTG's primary business?
- BTG (Bio-Technology General Israel) is an integrated biopharmaceutical services company that develops and manufactures healthcare products derived from genetic engineering and biotechnology processes.
- When was BTG founded?
- BTG was founded in September 1980.
- Which company acquired BTG and when?
- BTG was acquired by Ferring Pharmaceuticals in January 2005.
- What are some of BTG's key products?
- BTG's key products include Biolon, an injectable system for ophthalmic surgeries; Euflexxa, a treatment for osteoarthritis knee pain; and a recombinant human growth hormone for treating Turner syndrome and growth hormone deficiency.
- What was BTG's most recent funding round?
- BTG's most recent funding round occurred in May 2018, with Ferring Pharmaceuticals as an investor.
- What is the total amount of funding BTG has raised to date?
- BTG has raised a total of $26,930,000 USD.
- Who is the General Manager at BTG?
- Tal Levi is the General Manager at BTG.
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | btgil.com |
|---|---|
| linkedin.com/company/151809 | |
| facebook.com/btgil |
Identifiers & details
| Founded | 1980-9 |
|---|---|
| Employees (exact) | 348 |
| Status reason | Acquired by Ferring Pharmaceuticals on Jan, 2005 |
Acquisitions & public offerings
Acquired by Ferring Pharmaceuticals 2005-01
Radar intelligence
Patents
| EPO | 658 |
|---|
Publications (Crossref)
| Works | 10 |
|---|
Web history (Wayback)
| Domain | btgil.com |
|---|